For pregnant women who received the bivalent prefusion F subunit-based respiratory syncytial virus (RSV) vaccine (RSVpreF; Abrysvo), safety outcomes were similar to those who were not vaccinated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback